Thank you for the genuinely intellectual question. From my perspective, I always look at the cash to debt ratio before making an investment decision. I don't see a cash flow impact from the divestiture of SB which leads me to believe this was a sound decision. Over the past decade, I have focused most of my investment dollars in technology which has proven a much slower rate of return in the last 3 years. Therefore, I have refocused my investment strategy to companies with emerging therapies as well as select commodities. I have experienced a triple digit rate of return.
I wonder when the dumb ass shorts will get really screwed and lose everything. Dumb move shorting this company.
